Intravenous Infusions (XGHA:IIL) Total Inventories : GHS0.00 Mil (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Total Inventories?

Intravenous Infusions's total inventories for the quarter that ended in . 20 was GHS0.00 Mil. Intravenous Infusions's average total inventories from the quarter that ended in . 20 to the quarter that ended in . 20 was GHS0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Intravenous Infusions's Net-Net Working Capital per share for the quarter that ended in . 20 was GHSN/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intravenous Infusions Total Inventories Historical Data

The historical data trend for Intravenous Infusions's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Total Inventories Chart

Intravenous Infusions Annual Data

Trend

Total Inventories

Intravenous Infusions Semi-Annual Data

Total Inventories

Intravenous Infusions Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Intravenous Infusions (XGHA:IIL) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Intravenous Infusions's Net-Net Working Capital Per Share for the quarter that ended in . 20 is

	Net-Net Working Capital Per Share (Q: . 20 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(	+	0.75 *	+	0.5 *	-	N/A
-		-	)	/	0
=	N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Intravenous Infusions's Days Inventory for the six months ended in . 20 is calculated as:

Days Inventory	=	Average Total Inventories (Q: . 20 )	/	Cost of Goods Sold (Q: . 20 )	*	Days in Period
	=	0	/		*	365 / 2
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Intravenous Infusions's Inventory Turnover for the quarter that ended in . 20 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: . 20 )	/	Average Total Inventories (Q: . 20 )
	=		/	0
	=	N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intravenous Infusions's Inventory to Revenue for the quarter that ended in . 20 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: . 20 )	/	Revenue (Q: . 20 )
	=	0	/
	=

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Intravenous Infusions Total Inventories Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.